title: Regression of left ventricular hypertrophy and improvement of renal hemodynamics in hypertensive patients treated with quinapril.
abstract: Of 17 patients with mild to moderate essential hypertension, 8 showed echocardiographic evidence of left ventricular hypertrophy. Cardiac and renal function evaluated by glomerular filtration rate (GFR) were studied in all patients before and after 20 weeks of quinapril treatment. Systolic pressure decreased from 174.7 +/- 16.7 to 131.7 +/- 7.7 mmHg (p < .0001) and diastolic pressure decreased from 101.8 +/- 9.8 to 80 +/- 4.3 mmHg (p < .0001). Left ventricular mass index decreased in the eight patients with left ventricular hypertrophy (p < .01). Basal values of GFR were lower than normal in 41% of all patients; GFR increased significantly after 20 weeks of treatment (from 96.5 +/- 32.3 to 108.6 +/- 31.12 ml/min, p < .01); it decreased in only one patient. Patients reported few adverse effects to quinapril, and no important clinical laboratory abnormality was observed. Quinapril not only lowered arterial pressure, but it had a distinct effect on regression of left ventricular hypertrophy and favorable effects on renal function.
authors.affiliation: Cattedra di Geriatria, II Facoltà di Medicina e Chirurgia, Università degli Studi di Napoli, Italy.
authors.forename: L
authors.initials: L
authors.lastname: De Caprio
authors.forename: M L
authors.initials: ML
authors.lastname: De Rosa
authors.forename: A
authors.initials: A
authors.lastname: Di Palma
authors.forename: C
authors.initials: C
authors.lastname: Lirato
authors.forename: P
authors.initials: P
authors.lastname: Caccese
authors.forename: M
authors.initials: M
authors.lastname: Sestito
authors.forename: S
authors.initials: S
authors.lastname: Lastoria
authors.forename: A M
authors.initials: AM
authors.lastname: Cicatiello
authors.forename: F
authors.initials: F
authors.lastname: Rengo
mesh_terms: D000328:Adult; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects*; D004452:Echocardiography / Q000187:drug effects; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D006977:Hypertension, Renal / Q000188:drug therapy*; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy*; D007546:Isoquinolines / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D007668:Kidney / Q000000981:diagnostic imaging; D008297:Male; D008875:Middle Aged; D000077583:Quinapril; D011877:Radionuclide Imaging; D016037:Single-Blind Method; D044005:Tetrahydroisoquinolines
chemical_list: D000959:Antihypertensive Agents; D007546:Isoquinolines; D044005:Tetrahydroisoquinolines; D000077583:Quinapril